Treatment Challenges Are Prevalent Among Patients With Severe Chronic Pain

The use of analgesics, including narcotics, is the most common treatment for chronic pain.1,2 However, patients may not tolerate the associated adverse events as their dosage level gradually increases, or may not have enough pain relief at a dosage level low enough to minimize side effects.1,3,4

Important Safety Information

PRIALT is contraindicated in patients with:

  • A known hypersensitivity to ziconotide or any of its formulation components.
  • Any other concomitant treatment or medical condition that would render IT administration hazardous, such as the presence of infection at the microinfusion injection site, uncontrolled bleeding diathesis, and spinal canal obstruction that impairs circulation of cerebrospinal fluid (CSF).
  • A pre-existing history of psychosis.

Please see full Prescribing Information, including BOXED Warning, and click here for additional Important Safety Information.

References: 1. Feinberg, American Chronic Pain Association (ACPA), 2013. 2. Munir M, Enany N, Zhang JM. Nonopioid analgesics. Anesthesiol Clin. 2007;25(4):761-774. 3. Jovey RD. Use of opioid analgesics for the treatment of chronic noncancer pain—a consensus statement and guidelines from the Canadian Pain Society, 2002. Pain Res Manage. 2003;8(suppl A):3A-28A. 4. Eisenberg E. Time to modify the WHO analgesic ladder? Pain Clinical Updates. International Association for the Study of Pain. 2005.